Nutcracker Therapeutics News and Resources

Nutcracker Therapeutics, a biotechnology company known for its proprietary RNA technology platform, has announced new contract research, development, and manufacturing organization (CRDMO) capabilities. The company’s expansion aims to provide scalable, flexible solutions to support RNA drug developers from early discovery